what is aubagio
Teriflunomide (trade name Aubagio, marketed by Sanofi, also known as A77 1726) is the active metabolite of leflunomide.Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS).eriflunomide (trade name Aubagio, marketed by Sanofi, also known as A77 1726) is the active metabolite of leflunomide.